Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis
Authors:
Open Access
- 27 August 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 16 (11) , 1314-1323
Abstract
Liver grafts from donors positive for antibody to hepatitis B core antigen (anti-HBc) may be used for transplantation in patients with hepatitis B virus (HBV)–related liver disease, and an occult HBV infection may develop from either source. Liver biopsy was performed for 31 patients who remained seronegative for hepatitis B surface antigen for a median of 44.5 months (range = 13.6-126.4 months) and received nucleoside analogue prophylaxis post-transplant. Nineteen of these recipients (61%) had received anti-HBc–positive grafts. Intrahepatic total HBV DNA and covalently closed circular DNA (cccDNA) levels were quantified, and the sequence was analyzed. Intrahepatic total HBV DNA and cccDNA were detectable in 26 (84%) and 16 (52%) of the 31 recipients, respectively, and they were more common when the donor was positive for anti-HBc (95% versus 67%, P = 0.038). The intrahepatic HBV DNA level correlated with the recipient pretransplant serum HBV DNA level (P = 0.06), and the intrahepatic HBV cccDNA level correlated with the donor intrahepatic HBV cccDNA level (P = 0.06). A phylogenetic analysis of the isolated HBV DNA sequence revealed HBV infections of both donor and recipient origins. In conclusion, an occult HBV infection after liver transplantation can originate from both the donor and recipient despite prolonged nucleoside analogue prophylaxis. The presence of intrahepatic HBV cccDNA is attributable more to the persistence of preexisting intrahepatic HBV cccDNA from a donor with previous exposure. Liver Transpl 16:1314-1323, 2010. © 2010 AASLD.Keywords
This publication has 26 references indexed in Scilit:
- Hepatitis B and liver transplantation: 2008 updateReviews in Medical Virology, 2008
- Comprehensive Genetic and Epigenetic Analysis of Occult Hepatitis B from Liver Tissue SamplesClinical Infectious Diseases, 2008
- Occult hepatitis B virus infection in chronic liver disease: Full-length genome and analysis of mutant surface promoterGastroenterology, 2004
- Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆Gastroenterology, 2004
- Hbv Dna Persistence 10 Years After Liver Transplantation Despite Successful Anti–Hbs Passive ImmunoprophylaxisHepatology, 2003
- Kinetics of Hepadnavirus Loss from the Liver during Inhibition of Viral DNA SynthesisJournal of Virology, 2001
- De novo hepatitis B after liver transplantation from hepatitis B core antibody—Positive donors in an area with high prevalence of anti-HBc positivity in the donor populationLiver Transplantation, 2001
- High-Throughput Quantitative Analysis of Hepatitis B Virus DNA in Serum Using the TaqMan Fluorogenic Detection SystemHepatology, 2000
- A Novel PCR Technique UsingAlu-Specific Primers to Identify Unknown Flanking Sequences from the Human GenomeGenomics, 1995
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995